Brief Communication : Rituximab in HIV-Associated Multicentric Castleman DiseaseBOWER, Mark; POWLES, Tom; GAZZARD, Brian et al.Annals of internal medicine. 2007, Vol 147, Num 12, pp 836-839, issn 0003-4819, 4 p.Article

The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcomaBOWER, Mark; WEIR, Justin; FRANCIS, Nicholas et al.AIDS (London). 2009, Vol 23, Num 13, pp 1701-1706, issn 0269-9370, 6 p.Article

Clinical Features and Outcome in HIV-Associated Multicentric Castleman's DiseaseBOWER, Mark; NEWSOM-DAVIS, Tom; NARESH, Kikkeri et al.Journal of clinical oncology. 2011, Vol 29, Num 18, pp 2481-2486, issn 0732-183X, 6 p.Article

Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcomaSTEBBING, Justin; GAZZARO, Brian; NEWSOM-DAVIS, Tom et al.International journal of cancer. 2004, Vol 108, Num 3, pp 473-474, issn 0020-7136, 2 p.Article

Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman diseaseSTEBBING, Justin; ADAMS, Caroline; SANITT, Adam et al.Blood. 2011, Vol 118, Num 2, pp 271-275, issn 0006-4971, 5 p.Article

HIV-associated anal cancer: Has highly active antiretroviral therapy reduced the incidence or improved the outcome?BOWER, Mark; POWLES, Tom; NEWSOM-DAVIS, Tom et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 37, Num 5, pp 1563-1565, issn 1525-4135, 3 p.Article

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UKLETANG, Emilio; LEWIS, James J; MIRO, Jose M et al.AIDS (London). 2013, Vol 27, Num 10, pp 1603-1613, issn 0269-9370, 11 p.Article

A prognostic index for systemic AIDS-related non-hodgkin lymphoma treated in the era of highly active antiretroviral therapyBOWER, Mark; GAZZARD, Brian; STEBBING, Justin et al.Annals of internal medicine. 2005, Vol 143, Num 4, pp 265-273, issn 0003-4819, 9 p.Article